Here is a comprehensive overview of bronchopneumonia from Robbins, Cotran & Kumar - Pathologic Basis of Disease, Fishman's Pulmonary Diseases and Disorders, and Grainger & Allison's Diagnostic Radiology:
Bronchopneumonia (Lobular Pneumonia)
Definition
Bronchopneumonia is a pattern of acute bacterial pneumonia characterized by patchy, multifocal consolidation of the lung centered on bronchioles and extending to surrounding peribronchiolar alveoli. It is also called lobular pneumonia because involvement is at the lobular (rather than lobar) level.
Bronchopneumonia vs. Lobar Pneumonia
| Feature | Bronchopneumonia | Lobar Pneumonia |
|---|
| Distribution | Patchy, multifocal, lobular | Entire lobe uniformly consolidated |
| Location | Often bilateral, basal | Usually unilateral |
| Onset | Insidious | Abrupt |
| Typical patients | Elderly, debilitated, infants | Previously healthy adults |
| Causative organisms | S. aureus, H. influenzae, gram-negatives | S. pneumoniae (most common) |
Pathogenesis
Infection begins in the bronchi and bronchioles, causing:
- Epithelial ulceration of bronchial/bronchiolar walls
- Fibrinopurulent exudate filling the peribronchiolar alveoli
- Patchy segmental involvement, which may become confluent producing more homogeneous consolidation
The patchy involvement tends to be bilateral and basal because respiratory secretions tend to gravitate to the lower lobes.
Etiology - Common Causative Organisms
| Organism | Notes |
|---|
| Staphylococcus aureus | Most typical bronchopneumonic pattern; often after viral URI; bilateral in ~40%; risk of cavitation, abscesses, pneumatoceles |
| Haemophilus influenzae (non-encapsulated) | Common bronchopneumonic pattern |
| Chlamydophila pneumoniae | Segmental bronchopneumonic pattern |
| Mycoplasma pneumoniae | Segmental pattern; common in young adults in closed communities |
| Klebsiella pneumoniae | Prone to necrosis and abscess formation |
| Escherichia coli | Multilobar, predominantly lower lobes; seen in debilitated patients |
| Pseudomonas aeruginosa | Confluent, often extensive bronchopneumonia; frequent cavitation; nosocomial |
| Viral pneumonias | Many viruses produce a bronchopneumonic consolidation pattern |
Non-infectious causes also produce a bronchopneumonic pattern: aspiration of gastric contents, sarcoidosis, hypersensitivity pneumonitis, cryptogenic organizing pneumonia (COP), and autoimmune diseases.
Morphology (Gross and Microscopic)
Gross appearance:
- Consolidated foci are slightly elevated, dry, granular, gray-red to yellow
- Poorly delimited margins
- Most often multilobar, bilateral, and basal
Microscopic appearance:
- Neutrophil-rich exudate filling bronchi, bronchioles, and adjacent alveolar spaces
- Epithelial ulceration of bronchial walls
- No orderly staging (unlike the four stages of lobar pneumonia)
Clinical Features
- Fever (high, often with shaking chills)
- Productive cough with mucopurulent sputum (occasionally hemoptysis)
- Dyspnea
- Pleuritic chest pain and pleural friction rub if pleuritis is present
- On imaging: focal opacities (vs. whole-lobe radiopacity in lobar pneumonia)
- Auscultation: crepitations, reduced breath sounds over consolidated areas
Radiology:
- Chest X-ray: patchy, ill-defined areas of airspace consolidation, predominantly in lower lobes
- CT: centrilobular nodules, tree-in-bud opacities, lobular/segmental consolidation
Complications
- Lung abscess - tissue destruction and necrosis (especially with Klebsiella or Staphylococcus)
- Empyema - spread of infection to pleural cavity causing intrapleural fibrinopurulent reaction
- Bacteremia and septicemia - dissemination to heart valves (endocarditis), brain (abscess), meningitis, pericarditis, suppurative arthritis
- Cavitation - especially with S. aureus and Pseudomonas
- Pneumatoceles - thin-walled air cysts, especially in staphylococcal disease
- Pleural effusion - occurs in 30-50% with staphylococcal pneumonia
Treatment
- Identify the causative organism and determine antibiotic sensitivity - the keystone of therapy
- Empirical antibiotics targeting the likely pathogen based on clinical setting (community-acquired vs. hospital-acquired)
- Appropriately treated patients typically become afebrile within 48-72 hours of starting antibiotics
- Mortality in hospitalized patients with pneumonia is less than 10% when treated effectively; deaths usually occur from complications (empyema, meningitis, endocarditis) or in debilitated patients
Sources: Robbins, Cotran & Kumar - Pathologic Basis of Disease; Fishman's Pulmonary Diseases and Disorders, 2-Volume Set; Grainger & Allison's Diagnostic Radiology